Mercer and Xevant Announce Strategic Plan Optimization Solution for Employer-Sponsored Pharmacy Benefit Plans
23 9월 2019 - 10:18PM
Business Wire
Mercer, a global consulting leader in advancing health, wealth
and career, and Xevant, a leader in pharmacy benefit management
(PBM) performance optimization solutions, announce that the two
firms have entered into an agreement to provide employers with an
optimization solution using key analytical data to offer timely and
actionable insights into the cost and performance of their pharmacy
benefit plans.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20190923005517/en/
The importance of this solution is driven by deep concern among
employers regarding the skyrocketing costs of their prescription
drug plans, particularly specialty drugs. In fact, 68% of employers
recently rated “focused action to manage cost for specialty drugs”
as one of their top three health benefit strategies for the next
five years. *
The Mercer/Xevant pharmacy plan optimization solution addresses
this strategic priority by bringing together the power of Xevant’s
X3 real-time analytics platform and Mercer’s pharmacy consulting
specialists, actuaries and financial consultants. This unique
combination offers employers key analytics through:
- Real-time insights: Daily claims data feeds from more
than 20 PBMs and carriers
- Comprehensive data: More than 2500 standard reports on
key analytics
- Flexibility: Employer-specific dashboards to track key
metrics and cost drivers
Potential benefits and positive outcomes for employers who
select this solution can include:
- Quicker identification of hyper-inflationary drugs, such as
“compounds”
- Greater efficiency in managing pharmacy spend via alerts based
on employer-specific metrics
- Better PBM governance enabled by real-time updates on plan
performance versus contractual guarantees
- Stronger member and provider management by identifying
potentially inappropriate opioid utilization and/or prescribing
behavior
- Deeper view into various cost-saving plan options including
formularies, networks and utilization management programs
“Until now, employers have not had the right data, at the right
time, with the right analysis and insights to forecast trends and
drive meaningful changes within their pharmacy benefit offerings,”
said David Dross, Mercer’s Managed Pharmacy Specialty Practice
Leader. “We believe our collaboration with Xevant is a true
innovation for sponsors who want better foresight and outcomes from
their Rx spend.”
“Today’s employers are faced with the significant challenge of
navigating the dynamic pharmacy benefits environment without the
knowledge and automated tools that can drive meaningful, lasting
change,” said Brandon Newman, Co-founder and CEO of Xevant. “By
combining Mercer’s pharmacy insights and market leadership with
Xevant’s performance optimization software, plan sponsors can
efficiently achieve new levels of cost savings and improved member
health.”
To learn more about the Mercer/Xevant pharmacy plan optimization
solution, please visit www.mercer.com or www.xevant.com.
*Mercer National Survey of Employer-Sponsored Health Plans,
2018. Figures cited represent employers with 500 or more
employees.
About Mercer
Mercer delivers advice and technology-driven solutions that help
organizations meet the health, wealth and career needs of a
changing workforce. Mercer’s more than 25,000 employees are based
in 44 countries and the firm operates in over 130 countries. Mercer
is a business of Marsh & McLennan Companies (NYSE: MMC), the
world’s leading professional services firm in the areas of risk,
strategy and people with 76,000 colleagues and annualized revenue
approaching $17 billion. Through its market-leading businesses
including Marsh, Guy Carpenter and Oliver Wyman, Marsh &
McLennan helps clients navigate an increasingly dynamic and complex
environment. For more information, visit www.mercer.com. Follow
Mercer on Twitter @Mercer.
About Xevant
Xevant provides improved client performance and experiences by
converting data into immediate insight and savings opportunities.
Xevant’s highly customized approach automates client performance
optimization across the spectrum of pharmacy benefits. This results
in the highest levels of cost reduction, member health, and
administrative efficiency without the required use of
labor-intensive analytic solutions. Xevant’s automated, end-to-end
client performance technology is an industry game-changer. Learn
more about Xevant by visiting www.xevant.com. Learn about
#TeamXevant on social media. Facebook | LinkedIn | Twitter
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190923005517/en/
Micaela McPadden +1 212 345 0806
micaela.mcpadden@mercer.com
Marlon Medina +1 702 689 7512
marlon.medina@xevant.com
Marsh and McLennan Compa... (NYSE:MMC)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Marsh and McLennan Compa... (NYSE:MMC)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024